Neuchâtel, Neuchâtel, Switzerland
Biotech Executive | Translational Strategy | Building Science-Driven Ventures in Health Innovation With over 25 years of experience across the pharmaceutical, medtech, and biotech industries, I specialize in bridging science, strategy, and execution to bring impactful health solutions to market. From commercial operations at Sanofi to advisory and leadership roles in high-growth startups, I’ve supported companies through key inflection points—whether in diagnostics, therapeutics, or platform technologies. I’m particularly drawn to ventures operating at the intersection of public health needs and cutting-edge science. My work spans preclinical development, industrial scale-up, regulatory strategy, and international partnerships—across both private and public spheres. Since 2020, I’ve served as CEO of Fab’entech, where we are expanding the potential of polyclonal antibody technologies for unmet medical needs. Under my leadership, the company has entered a new phase of growth—marked by European collaborations, strategic funding, and diversification beyond its historical focus areas. I’m driven by a simple idea: when innovation is guided by purpose and built on trust, it delivers lasting value—for patients, health systems, and society.
• Lead the transformation from an R&D company to a commercial stage • Increase company valuation through advancing pre-clinical / clinical programs and setting up manufacturing capabilities • Build a comprehensive team incl. R&D, Quality, Pharmaceutical Affairs, Industrial Operations and Business Development • Ensure fund raising and non-dilutive financing and initiate series B
• Prepare fund-raising activities for Seed rounds and Series A including investors relationships • Identify business opportunities and define market segments; prepare business plans, go-to-market strategies and all pre-launch plans • Lead marketing initiatives to increase company visibility and support product launches • Financial reporting to the board.
• Management of European Sales operations in Italy, Germany, UK and Benelux and distributors in other European countries • Regulatory, Market access & business development (licensing) strategies • Elaboration of Strategic Business plans for key countries
• Manage 12 affiliates and distributors, define commercial strategies, recruit new talents • Define International strategy aiming at doubling the sales between 2015 – 2020 • Hire and manage business analytics and international marketing teams. • Drive marketing strategies resulting in increased market shares, optimized brand value, rationalized portfolio and improved margins • M&A: Identification of potential acquisitions
• Set up and manage 8 new affiliates: Poland, Czech Republic, Slovakia, Austria, Switzerland, UK/Ireland, Russia, Turkey & Middle-East • Define regulatory and market access strategies with successful product launches • Lead marketing teams in product launch phases: Market Research, Targeting and Segmentation, brand strategies, business forecasts • Lead the Sales Force Efficiency program at global level
• Set-up the affiliate, define strategy, recruit and manage teams. • Define and implement marketing & commercial strategies • Support Market access strategies including pharmaco-economics supportive programs • KOL management • Business Development: Screening of potential partners and acquisitions
Management of distributors in Europe and Asia. (25 countries) • Evaluate markets potential • Define Marketing and Commercial strategies • Manage distributors network